Log in to save to my catalogue

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membr...

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_75733453

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

About this item

Full title

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2003-10, Vol.112 (7), p.1029-1036

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Eosinophil-derived TGF-beta has been implicated in remodeling events in asthma. We hypothesized that reduction of bronchial mucosal eosinophils with anti-IL-5 would reduce markers of airway remodeling. Bronchial biopsies were obtained before and after three infusions of a humanized, anti-IL-5 monoclonal antibody (mepolizumab) in 24 atopic asthmatic...

Alternative Titles

Full title

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_75733453

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_75733453

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/jci17974

How to access this item